Macphylline Capsule contains Acebrophylline 100mg, a bronchodilator and mucolytic agent used primarily in the management of respiratory conditions characterized by bronchospasm and excessive mucus production, such as chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. Acebrophylline exerts its therapeutic effect by relaxing the smooth muscles of the bronchial airways, thereby improving airflow and facilitating easier breathing. Additionally, it enhances mucociliary clearance by reducing mucus viscosity, which aids in the expectoration of sputum and helps prevent mucus plugging. The dual action of bronchodilation and mucolysis makes Macphylline Capsule effective in relieving symptoms like wheezing, breathlessness, and productive cough. It is generally well-tolerated, with a safety profile that supports its use as an adjunct to conventional therapy in obstructive airway diseases. Macphylline should be administered as prescribed by a healthcare professional, with dosage adjusted according to the severity of the condition and patient response. Caution is advised in patients with hypersensitivity to xanthine derivatives, and it should be used under medical supervision in individuals with cardiovascular disorders. Regular monitoring is recommended to assess therapeutic efficacy and detect any adverse effects.